Hengehold Capital Management LLC Grows Stock Holdings in Teleflex Incorporated (NYSE:TFX)

Hengehold Capital Management LLC grew its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 17.2% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,201 shares of the medical technology company’s stock after purchasing an additional 176 shares during the quarter. Hengehold Capital Management LLC’s holdings in Teleflex were worth $297,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in the business. Goldman Sachs Group Inc. boosted its stake in Teleflex by 11.5% in the 4th quarter. Goldman Sachs Group Inc. now owns 171,959 shares of the medical technology company’s stock worth $42,876,000 after buying an additional 17,669 shares during the last quarter. Vanguard Group Inc. grew its holdings in Teleflex by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 5,454,016 shares of the medical technology company’s stock valued at $1,359,904,000 after purchasing an additional 57,132 shares during the period. Nomura Holdings Inc. acquired a new position in Teleflex during the fourth quarter worth approximately $237,000. Mather Group LLC. purchased a new position in Teleflex during the first quarter worth approximately $59,000. Finally, Bridge Creek Capital Management LLC boosted its holdings in shares of Teleflex by 2.7% in the 1st quarter. Bridge Creek Capital Management LLC now owns 16,263 shares of the medical technology company’s stock valued at $3,678,000 after purchasing an additional 430 shares during the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

Insider Transactions at Teleflex

In related news, Director Stuart A. Randle sold 2,674 shares of the company’s stock in a transaction on Friday, August 16th. The shares were sold at an average price of $238.93, for a total value of $638,898.82. Following the sale, the director now directly owns 5,496 shares of the company’s stock, valued at $1,313,159.28. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 1.43% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently weighed in on the company. Piper Sandler raised Teleflex from a “neutral” rating to an “overweight” rating and increased their target price for the stock from $205.00 to $245.00 in a research report on Monday, July 1st. Stephens raised their price objective on Teleflex from $275.00 to $290.00 and gave the stock an “overweight” rating in a report on Friday, August 2nd. Royal Bank of Canada boosted their target price on Teleflex from $260.00 to $275.00 and gave the stock an “outperform” rating in a report on Tuesday, October 8th. Finally, Truist Financial raised their price target on shares of Teleflex from $247.00 to $255.00 and gave the company a “hold” rating in a report on Monday. Three equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $268.86.

Teleflex Price Performance

Shares of TFX stock opened at $234.14 on Friday. Teleflex Incorporated has a twelve month low of $177.63 and a twelve month high of $257.85. The company has a market capitalization of $11.03 billion, a PE ratio of 42.04, a price-to-earnings-growth ratio of 2.15 and a beta of 1.16. The company has a current ratio of 2.58, a quick ratio of 1.44 and a debt-to-equity ratio of 0.36. The firm has a fifty day simple moving average of $240.63 and a 200-day simple moving average of $222.85.

Teleflex (NYSE:TFX) last announced its earnings results on Thursday, August 1st. The medical technology company reported $3.42 earnings per share for the quarter, beating the consensus estimate of $3.33 by $0.09. Teleflex had a return on equity of 14.51% and a net margin of 8.76%. The company had revenue of $749.70 million during the quarter, compared to the consensus estimate of $762.98 million. During the same period last year, the firm earned $3.41 earnings per share. The company’s revenue was up .9% on a year-over-year basis. Equities research analysts anticipate that Teleflex Incorporated will post 13.97 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, September 16th. Stockholders of record on Thursday, August 15th were paid a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 0.58%. The ex-dividend date of this dividend was Thursday, August 15th. Teleflex’s dividend payout ratio (DPR) is currently 24.42%.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.